Publications:

PCSK9 prosegment chimera as novel inhibitors of LDLR degradation.

Plos One

Saavedra, Yascara Grisel Luna YG; Zhang, Jianbing J; Seidah, Nabil G NG

Publication Date: 2013

Variant appearance in text: PCSK9: Q152W

PubMed Link: 23951290

Variant Present in the following documents:

• Main text
• pone.0072113.pdf

View BVdb publication page

Loss- and gain-of-function PCSK9 variants: cleavage specificity, dominant negative effects, and low density lipoprotein receptor (LDLR) degradation.

The Journal Of Biological Chemistry

Benjannet, Suzanne S; Hamelin, Josée J; Chrétien, Michel M; Seidah, Nabil G NG

Publication Date: 2012-09-28

Variant appearance in text: PCSK9: Q152W

PubMed Link: 22875854

Variant Present in the following documents:

• Main text

View BVdb publication page